Featuring an interview with Professor Juan Valle, including the following topics:
- Immunotherapy for patients with biliary tract cancers (BTCs) (0:00)
- Etiology and presentation of and recent advances in the management of cholangiocarcinoma (4:18)
- Targeting FGFR alterations in cholangiocarcinoma and other BTCs (12:47)
- Spectrum and management of toxicities associated with FGFR inhibitors (19:33)
- Targeting driver mutations beyond FGFR (28:16)
- Case: A man in his early 60s with intrahepatic cholangiocarcinoma, an FGFR2 fusion and an IDH1 R132C mutation (35:53)
- Case: A woman in her early 60s with intrahepatic cholangiocarcinoma and an IDH1 mutation that did not respond to third-line ivosidenib (41:49)
- Case: A woman in her early 60s with gallbladder cancer who received first-line chemotherapy with pembrolizumab (46:15)
CME information and select publications
Research To Practice | Oncology Videos